Quick Answer
TELA Bio, Inc. reported Operating Income of -$33.76 million for fiscal year 2025.
TELA Bio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$33.76M | +1.1% |
| 2024 | -$34.12M | +22.6% |
| 2023 | -$44.08M | -13.0% |
| 2022 | -$39.01M | -32.4% |
| 2021 | -$29.45M | -16.5% |
| 2020 | -$25.27M | -31.9% |
| 2019 | -$19.16M | -7.8% |
| 2018 | -$17.78M | -5.1% |
| 2017 | -$16.92M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.55M | +19.3% | +16.8% |
| June 30, 2025 | -$9.08M | +21.5% | +13.3% |
| March 31, 2025 | -$10.47M | -117.0% | -11.8% |
| September 30, 2024 | -$9.37M | +8.0% | +19.1% |
| June 30, 2024 | -$11.57M | -11.7% | -139.7% |
| March 31, 2024 | -$4.83M | +57.1% | +52.6% |
| September 30, 2023 | -$10.18M | -7.3% | +1.7% |
| June 30, 2023 | -$10.36M | -1.2% | +7.9% |
- TELA Bio, Inc. showed an increase of +1.1% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, TELA Bio, Inc.’s operating income has declined by 99.5% (from -$16.92 million to -$33.76 million).
- The most recent figure is from TELA Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: